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Abstract
This paper presents a case of the moderate form of Leukocyte adhesion deficiency type 1 (LAD-1) in a 4 year-old 
boy. LAD-1 is a rare, inherited immunodeficiency that affects 1 in 1 million people yearly. Affected patients are 
susceptible to recurrent bacterial and fungal infections, impaired pus formation and delayed wound healing. In 
the oral clinical finding, more important is a generalized prepuberal periodontitis that can affect the primary and 
permanent dentitions. For this reason cooperation between dentists and pediatricians is essential in these patients. 
Evaluating immune system in these patients included peripheral blood leukocyte counts, measurement of serum 
immunoglobulin levels, assessment of complement level and function, flow cytometric analysis of lymphocyte 
subsets, and tests of phagocytic function (nitrobluetetrazolium test (NBT)). In families with known molecular 
defect, an earlier prenatal diagnosis is possible by chorionic villi biopsy. The most important focus should be to 
control infections. Treatment includes systemic antibiotics and in many cases bone marrow transplantation.
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Introduction
Leukocyte adhesion deficiency (LAD) is a rare primary 
immunodeficiency disease (1). There are three types of 
LAD syndromes, LAD-I, II and III (also referred to as 
variant LAD-I) (2). LAD-I results from a mutation in 
the gene encoding the CD18 adhesion molecule. This 
mutation results in absent or severely reduced leukocyte 
cell surface expression of ß2 integrin molecules, which 
are essential to the adhesion of leukocytes to endothelial 
cells, transendothelial migration, and chemotaxis (3,4). 
There is failure of innate host defenses against bacteria, 
fungi and other microorganisms resulting from defec-
tive adhesion and targeting of myeloid leukocytes to 
sites of microbial invasion (5). In type II, the primary 
genetic defect is in a specific Golgi GDP-fucose trans-
porter leading to poor formation of CD15. It is charac-
terized by recurrent infections, persistent leucocytosis, 
and severe mental and growth retardation. Type III is a 
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rare disease with defects in the integrin activation proc-
ess (mutation in kindling-3), and presents with both the 
immunodeficiency of LAD-I as well as severe bleeding 
disorders (6). Our patient, a 4 year-old boy with peri-
odontitis as a manifestation of systemic diseases (Mod-
erate LAD-I) and cellulitis. The purpose of this report is 
to stress the role of dentist in managing these medically 
compromised children.
Case report
A 4 year-old boy (Fig. 1) reported with a complaint of 
pain in his upper and lower jaw since one month and 
swelling in right lower jaw since one week. Pain was 
severe and radiating in nature. Patient was diagnosed 
as moderate LAD-I when he was 2 years of age and the 
past medical history revealed significant recurrent res-
piratory and gastrointestinal infections, starting from 
the time of birth necessitating three to four hospitaliza-
tions per year. The patient was a full term baby, born to 
second degree consanguineous parents. The two elder 
siblings died at 3 months and 2 months, but the cause 
of their death is unknown. Generally there is a history 
of delayed umbilical separation, but was absent in our 
case. Patients with the moderate phenotype are usually 
diagnosed later in life and do not typically have delayed 
umbilical cord separation.
General physical examination revealed that the patient 
was moderately built and poorly nourished, conscious, 
oriented and cooperative. Pallor was positive and bilat-
eral submandibular lymph nodes were palpable, tender, 
firm in consistency, and movable. On presentation, pa-
tient was febrile and a firm, tender extraoral swelling 
was evident on the right lower third of the face. The 
facial skin demonstrated hyper and hypo pigmented 
patches and the skin appeared scaly and dry, especially 
around the nose and mouth characteristic of eczema. 
The lips were chapped and swollen with white fissures 
at the angle of mouth, suggestive of candidiasis. Exami-
nation of other cutaneous sites revealed large scar on the 
scalp and left elbow.
Intraorally (Fig. 2), there was generalized mobility of 
teeth and multiple carious teeth in anterior maxilla and 
posterior mandible. Caries was due to the neglected 
oral hygiene, since patient was scared of bleeding upon 
brushing his teeth. Caries is not typical of this disease. 
Gingival examination revealed generalized inflamma-
tion which was diffuse involving marginal, interdental 
and attached gingiva. Generalized enlargement of mar-
ginal and interdental gingiva was noted and was more 
lingually. Grade III bleeding on probing was present. 
Probing depth was in the range of 7-8 mm and clinical 
attachment level (CAL) was in the range of 5-7 mm, and 
examination of tongue revealed benign migratory glos-
sitis. There was enlargement of palatine tonsils. 
Panoramic radiograph (Fig. 3) revealed severe general-
Fig. 1. Patient photograph showing diffuse swell-
ing on the right lower third of face.

Fig. 2. Intraoral photograph.

Fig. 3. Preoperative Panoramic radiograph showing severe general-
ized alveolar bone loss.

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ized alveolar bone loss giving a floating tooth appear-
ance. Laboratory values of our case are tabulated (Table 
1). Bombay blood group was absent in our case, which 
is usually present in LAD-II.
The final diagnosis of periodontitis as a manifestation 
of systemic disease and cellulitis due to LAD type I was 
given based on the history, clinical features and inves-
tigatory reports. Patient was admitted and treated with 
injection Cefepime 500 mg and injection Amikacin 75 
mg intravenously BD and syrup Crocin (acetaminophen) 
120mg/5ml was advised to be taken orally, as required 
for 10 days. After controlling the infection, we recorded 
patient s´ hygiene performance index (Podshadley A.G 
and Haley. J.V 1965) which was fair (score-3.1) and gin-
gival index (Leo.H and Silness.J 1963) which was severe 
(score-2.8). Scaling and root planning was performed 
Hematologicalinvestigations Reportedvalue Referenceintervals
Hemoglobin 8.9gm/dL 14.5gm/dL
CBCprofile 
TotalWBCcount 35200/microlitre 4000Ͳ11000
Neutrophils 56% 40Ͳ74
Lymphocytes 38% 20Ͳ40
Eosinophils 04% 1Ͳ7
Monocytes 02% 1Ͳ9
Plateletcount 585000/mm3 1.5Ͳ4.5
MCV 64.8fL 80Ͳ100
MCH 20.0PG 27Ͳ31
MCHC 30.9G/dL 32Ͳ36
RDW 20.4% 11Ͳ15
ESR 55mm/hr 0Ͳ9
Immunoglobulin
IgG 3069mg% 206Ͳ601
IgA 479mg% 28Ͳ47
IgM 111mg% 17Ͳ105
Bonemarrow Solidlycellularmarrowwithmildmyeloidhyperplasiaand
nonspecificreactivechanges.
Biopsy Scantymainlysubcorticalmarrowwithnosignificantlesion
bytrephinebiopsy.
LDH 433U/L 150Ͳ300
Creatinine 0.5mg% 0.6Ͳ1.3
SerumCalcium&Phosphate
Calcium 9.4mg/dL 9Ͳ11.5
Phosphorus 5.4mg/dL 4.5Ͳ6
Liverfunctiontests
Albumin 3.5gm% 3.4Ͳ5
SGOT 32U/L 15Ͳ37
SGPT 12U/L 30Ͳ65
Alkalinephosphatase 195U/L 50Ͳ136
Serumpotassium 3.5mmol/L 3.7Ͳ5.2
Bloodbornevirusscreen
HIV  Ͳ
HbsAg  Ͳ
HCV  Ͳ
CD11aͲ2.32%,CD11bͲ8.7%,CD11cͲ9.4%
CD3Ͳ58.5%,CD4Ͳ45.4%,CD8Ͳ16.5%,CD19Ͳ9.8%(normal)
Bombaybloodgroupantigen Absent
Peripheralsmear Microcytichypochromicanemia

Table 1. Laboratory values.
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and severely mobile mandibular right primary second 
molar and maxillary left primary second molar teeth 
were extracted followed by primary closure of gingival 
tissues. Antiseptic mouthwash (Chlorhexidine-0.12%) 
was prescribed and fluoride application was done (APF 
gel). 
Oral health regimen for follow up: Patient is under pe-
riodic examination (every 3 months). During examina-
tion, we subjected the patient for oral and general physi-
cal examination. Professional oral prophylaxis was done 
after recording hygiene performance index, gingival 
index, probing depth and CAL. Parents were counseled 
to provide a nutritious diet to the child and were ad-
vised to take care of the skin and mucous membrane to 
protect against injury. Parent counseling, oral hygiene 
instruction included brushing his teeth twice daily and 
antiseptic mouth rinse after every meal. We adminis-
tered a dose of amoxicillin (5mg/kg) 2 hrs before dental 
treatment and continued this prophylaxis twice a day 
for the next 2 days.
Panoramic radiographs were taken yearly with no pro-
gressive bone loss in the first year. There was sponta-
neous exfoliation of 31,51,52,53,61,62,75 and 83. Pano-
ramic radiograph taken during second year of follow up 
revealed increased alveolar bone level; especially in the 
mandibular premolar region. 
There was significant improvement in his oral health 
and decrease incidence of oral infections; especially 
abscesses and facial swelling during second year fol-
low up. Patient was admitted in our hospital and treated 
thrice in two years for respiratory infection, but did not 
develop orofacial infections in this period. We noticed 
bilateral submandibular lymph node enlargement twice 
in his follow up visits. At present he is under regular 
follow up.
Discussion
Leukocyte adhesion deficiency type I was first de-
scribed as a separate entity among immunodeficiencies 
in 1979 by Kuijpers et al. (7). Since then number of case 
reports are published, with few reports on oral manifes-
tations and management of oral infections. LAD-I is a 
rare, inherited, autosomal recessive, immunodeficiency 
disease caused by the combined loss of expression on 
the surface of leukocytes of the leukocyte integrins 
LFA-1, Mac-1, and pl50, 95 (8). It usually presents in 
infancy or early childhood, with recurrent life-threat-
ening bacterial infections, impaired pus formation, and 
wound healing (9,10). Two relatively distinct clinical 
phenotypes of LAD I have been described. Based on 
degree of expression, the disease was subdivided into 
severe (<1% expression of CD18) and moderate (1–30% 
expression of CD18) phenotypes (11).
Patients with the severe form of the disease tend to suc-
cumb early in life to overwhelming infection, whereas, 
those with a moderate form of the disease often survive 
through it to adulthood (12). Oral candidiasis is also a 
frequently observed symptom and must be treated ag-
gressively (13). 
The diagnosis of LAD I was based on typical clinical 
presentation including recurrent severe infections, im-
paired pus formation, impaired wound healing, com-
bined with laboratory demonstration of leukocytosis, 
significant reduction (moderate phenotype) or near 
absence (severe phenotype) of CD18 and its associated 
molecules CD11a, CD11b, CD11c on leukocytes. 
Therapeutic strategies in these patients should concen-
trate on prevention of local (dental) and systemic infec-
tions. Teeth must be preserved whenever possible, and 
periodontal disease should be controlled with periodic 
oral prophylaxis for the sake of maintaining normal 
physical and psychologic development of the child (3). 
Hematopoietic stem cell transplantations are gold stand-
ard therapies and have a very high success rate. How-
ever, retroviral mediated gene replacement may be the 
treatment of the future because; a low level of correc-
tion of expression of ß2 would provide clinical benefits.
Roberts et al. (14) conducted a 5-year case study of a 
child with LAD I, described the generalized progressive 
periodontitis and intraoral infections and concluded 
that the associated therapeutic challenges used in the 
attempts to arrest the periodontal disease were largely 
unsuccessful, but in our case there was a improvement 
in his periodontal condition. 
We noticed significant improvement in alveolar bone 
level which was mainly due to the strict oral health regi-
men, control of infection and extraction of the offending 
teeth. This tissue condition allowed alveolar bone de-
velopment around tooth follicle during odontogenesis. 
We recommend extraction of offending teeth, but not all 
the mobile teeth. Since there is early alveolar bone loss, 
there will be generalized mobility. Clinician should 
thoroughly examine and advice extraction of offend-
ing teeth which causes repeated infection, following up 
with oral health regimen. Finally, oral swabs and blood 
cultures should be performed in cases of LAD-I when 
there is any episode of suspected infection, so that opti-
mal measures can be taken through the use of appropri-
ate antibiotics.
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